MIAMI, Jan. 16, 2013 /PRNewswire/ -- FUISZ LLC today announced it had filed a patent application with the USPTO for smartphone technology that provides unique advantages and capabilities over those presently in use.
Joseph Fuisz, managing member of FUISZ commented: "Despite remarkable advances in smartphone processing power and improving network capabilities, the actual smartphone telephony functionality in use stubbornly refuses to advance. In this new system, we employ a novel software-based architecture that enables advanced telephony feature deployment without requiring network change or carrier participation. We envisage that this new architecture will allow for the organic growth in novel, advanced telephony features."
Richard Fuisz M.D (http://en.wikipedia.org/wiki/Richard_Fuisz), founding member of FUISZ further commented: "In addition to human use, the extension of this new technology into the world of machine communication is particularly exciting. For example, this technology extends the system described in our prior fluid analyzer patent (US 7,824,612) to a new level of sophistication for the physician and for the patient."
Fuisz LLC is a private technology company originated by the Fuiszes. The Fuiszes have made substantial contributions in drug delivery including orally dissolving tablets and novel particle coating systems at Fuisz Technologies; inventing and developing thin film drug delivery technologies at Kosmos Pharma and MonoSol Rx, as well as independently developing extruded sheet technology and diagnostic applications. Fuisz has extensive experience working with big and specialty pharma, as well as large consumer products companies. Fuisz has its headquarters in Miami. www.fuisz.com
SOURCE Fuisz LLC